Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1

Expert Review of Proteomics

Volumn 8, Issue 6, 2011, Pages 759-774

  Pic, Emilie ^a   Gagné, Jean Philippe ^a   Poirier, Guy G ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

mass spectrometry; poly(ADP ribose); poly(ADP ribose) polymerase 1; post translational modification; proteomics

Indexed keywords

BRCA2 PROTEIN; CISPLATIN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KU ANTIGEN; LYSINE; MEMBRANE PROTEIN; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEAR PROTEIN; POLYANION; RIBONUCLEOPROTEIN; SOMATOMEDIN C RECEPTOR; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; TRANSCRIPTION FACTOR FKHR; WERNER SYNDROME PROTEIN;

ARCHAEBACTERIUM; CARCINOGENIC ACTIVITY; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHROMATOGRAPHY; DNA DAMAGE; DNA SEQUENCE; ENZYME ACTIVE SITE; FAR WESTERN BLOTTING; FUNCTIONAL PROTEOMICS; HUMAN; IMMUNOPRECIPITATION; INFLUENZA VIRUS A; MASS SPECTROMETRY; MITOCHONDRION; MITOSIS; MUTAGENESIS; NONHUMAN; OOCYTE MATURATION; PANCREAS ADENOCARCINOMA; PROSTATE CANCER; PROTEIN PURIFICATION; REVIEW; RNA STABILITY; TRANSCRIPTION REGULATION; VIRUS REPLICATION; XENOPUS LAEVIS;

HUMANS; MASS SPECTROMETRY; POLY(ADP-RIBOSE) POLYMERASES; PROTEOMICS;

EID: 81555212331     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.11.63     Document Type: Review

References (165)

1. Kraus WL. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr. Opin. Cell. Biol. 20(3), 294-302 (2008).
2. Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39(1), 8-24 (2010).
3. Mendoza-Alvarez H, Alvarez-Gonzalez R. Poly(ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular. J. Biol. Chem. 268(30), 22575-22580 (1993).
4. Pion E, Ullmann GM, Ame JC, Gerard D, de Murcia G, Bombarda E. DNA-induced dimerization of poly(ADP-ribose) polymerase-1 triggers its activation. Biochemistry 44(44), 14670-14681 (2005).
5. Droit A, Hunter JM, Rouleau M et al. PARPs database: a LIMS systems for protein-protein interaction data mining or laboratory information management system. BMC Bioinformatics 8, 483 (2007).
6. Gagne JP, Shah RG, Poirier GG. Analysis of ADP-ribose polymer sizes in intact cells. Mol. Cell. Biochem. 224(1-2), 183-185 (2001).
7. Clamp M, Fry B, Kamal M et al. Distinguishing protein-coding and noncoding genes in the human genome. Proc. Natl Acad. Sci. USA 104(49), 19428-19433 (2007).
8. Gingras AC, Gstaiger M, Raught B, Aebersold R. Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell. Biol. 8(8), 645-654 (2007).
9. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21(3), 255-261 (2003).
10. Johnson H, Eyers CE. Analysis of post-translational modifications by LC-MS/MS. Methods Mol. Biol. 658, 93-108 (2010).
11. May C, Brosseron F, Chartowski P, Schumbrutzki C, Schoenebeck B, Marcus K. Instruments and methods in proteomics. Methods Mol. Biol. 696, 3-26 (2011).
12. Oeljeklaus S, Meyer HE, Warscheid B. New dimensions in the study of protein complexes using quantitative mass spectrometry. FEBS Lett. 583(11), 1674-1683 (2009).
13. Chandramouli K, Qian PY. Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum. Genomics Proteomics 2009, 239204 (2009).
14. Otto H, Reche PA, Bazan F, Dittmar K, Haag F, Koch-Nolte F. In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs). BMC Genomics 6, 139 (2005).
15. Ame JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays 26(8), 882-893 (2004).
16. Kleine H, Poreba E, Lesniewicz K et al. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell. 32(1), 57-69 (2008).
17. Haince JF, Kozlov S, Dawson VL et al. Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J. Biol. Chem. 282(22), 16441-16453 (2007).
18. Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front. Biosci. 13, 3046-3082 (2008).
19. Frizzell KM, Gamble MJ, Berrocal JG et al. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J. Biol. Chem. 284(49), 33926-33938 (2009).
20. Isabelle M, Moreel X, Gagne JP et al. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Sci. 8, 22 (2010).
21. Jiang H, Kim JH, Frizzell KM, Kraus WL, Lin H. Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases. J. Am. Chem. Soc. 132(27), 9363-9372 (2010).
22. Tao Z, Gao P, Liu HW. Studies of the expression of human poly(ADP-ribose) polymerase-1 in Saccharomyces cerevisiae and identification of PARP-1 substrates by yeast proteome microarray screening. Biochemistry 48(49), 11745-11754 (2009).
23. Gagné JP, Hunter JM, Labrecque B, Chabot B, Poirier GG. A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)- binding proteins. Biochem. J. 371(Pt 2), 331-340 (2003).
24. Ji Y, Tulin AV. Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing. Nucleic Acids Res. 37(11), 3501-3513 (2009).
25. Gagne JP, Isabelle M, Lo KS et al. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res. 36(22), 6959-6976 (2008).
26. Lai Y, Chen Y, Watkins SC et al. Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J. Neurochem. 104(6), 1700-1711 (2008).
27. Lapucci A, Pittelli M, Rapizzi E, Felici R, Moroni F, Chiarugi A. Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription. Mol. Pharmacol. 79(6), 932-940 (2011).
28. Andrabi SA, Dawson TM, Dawson VL. Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann. NY Acad. Sci. 1147, 233-241 (2008).
29. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342(Pt 2), 249-268 (1999).
30. Haince JF, McDonald D, Rodrigue A et al. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J. Biol. Chem. 283(2), 1197-1208 (2008).
31. Leppard JB, Dong Z, Mackey ZB, Tomkinson AE. Physical and functional interaction between DNA ligase IIIa and poly(ADP-ribose) polymerase 1 in DNA single-strand break repair. Mol. Cell. Biol. 23(16), 5919-5927 (2003).
32. Heale JT, Ball AR Jr, Schmiesing JA et al. Condensin I interacts with the PARP-1- XRCC1 complex and functions in DNA single-strand break repair. Mol. Cell. 21(6), 837-848 (2006).
33. Zhu G, Lippard SJ. Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA interstrand cross-links. Biochemistry 48(22), 4916-4925 (2009).
34. Khodyreva SN, Prasad R, Ilina ES et al. Apurinic/apyrimidinic (AP) site recognition by the 5′-dRP/AP lyase in poly(ADP-ribose) polymerase-1 (PARP-1). Proc. Natl Acad. Sci. USA 107(51), 22090-22095 (2010).
35. Lebel M, Lavoie J, Gaudreault I, Bronsard M, Drouin R. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice. Am. J. Pathol. 162(5), 1559-1569 (2003).
36. Adelfalk C, Kontou M, Hirsch-Kauffmann M, Schweiger M. Physical and functional interaction of the Werner syndrome protein with poly-ADP ribosyl transferase. FEBS Lett. 554(1-2), 55-58 (2003).
37. Li B, Navarro S, Kasahara N, Comai L. Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1. J. Biol. Chem. 279(14), 13659-13667 (2004).
38. Lachapelle S, Gagne JP, Garand C et al. Proteome-wide identification of WRN-interacting proteins in untreated and nuclease-treated samples. J. Proteome Res. 10(3), 1216-1227 (2011).
39. von Kobbe C, Harrigan JA, Schreiber V et al. Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein. Nucleic Acids Res. 32(13), 4003-4014 (2004).
40. Yin H, Glass J. In prostate cancer cells the interaction of C/EBPalpha with Ku70, Ku80, and poly(ADP-ribose) polymerase-1 increases sensitivity to DNA damage. J. Biol. Chem. 281(17), 11496-11505 (2006).
41. Ahel D, Horejsi Z, Wiechens N et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325(5945), 1240-1243 (2009).
42. Gottschalk AJ, Timinszky G, Kong SE et al. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc. Natl Acad. Sci. USA 106(33), 13770-13774 (2009).
43. Kanno S, Kuzuoka H, Sasao S et al. A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses. EMBO J. 26(8), 2094-2103 (2007).
44. Fang Y, Liu T, Wang X et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 25(25), 3598-3605 (2006).
45. Chang W, Dynek JN, Smith S. NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem. J. 391(Pt 2), 177-184 (2005).
46. Saxena A, Saffery R, Wong LH, Kalitsis P, Choo KH. Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl)ated. J. Biol. Chem. 277(30), 26921-26926 (2002).
47. Chang P, Coughlin M, Mitchison TJ. Interaction between poly(ADP-ribose) and NuMA contributes to mitotic spindle pole assembly. Mol. Biol. Cell. 20(21), 4575-4585 (2009).
48. Compton DA. Mitosis: PARty time in the spindle. Curr. Biol. 15(5), R178-R179 (2005).
49. Ding W, Liu W, Cooper KL et al. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 284(11), 6809-6817 (2009).
50. Zhou X, Sun X, Cooper KL, Wang F, Liu KJ, Hudson LG. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J. Biol. Chem. 286(26), 22855-22863 (2011).
51. Rossi MN, Carbone M, Mostocotto C et al. Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J. Biol. Chem. 284(46), 31616-31624 (2009).
52. Simbulan-Rosenthal CM, Rosenthal DS, Hilz H et al. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry 35(36), 11622-11633 (1996).
53. Jump DB, Butt TR, Smulson M. Nuclear protein modification and chromatin substructure. 3. Relationship between poly(adenosine diphosphate) ribosylation and different functional forms of chromatin. Biochemistry 18(6), 983-990 (1979).
54. Naryzhny SN. Proliferating cell nuclear antigen: a proteomics view. Cell. Mol. Life Sci. 65(23), 3789-3808 (2008).
55. Frouin I, Maga G, Denegri M et al. Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. J. Biol. Chem. 278(41), 39265-39268 (2003).
56. Si H, Verma SC, Robertson ES. Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J. Virol. 80(18), 9017-9030 (2006).
57. Wang Y, Li H, Tang Q, Maul GG, Yuan Y. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J. Virol. 82(6), 2867-2882 (2008).
58. Mayer D, Molawi K, Martinez-Sobrido L et al. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J. Proteome Res. 6(2), 672-682 (2007).
59. Gordon-Shaag A, Yosef Y, Abd El-Latif M, Oppenheim A. The abundant nuclear enzyme PARP participates in the life cycle of simian virus 40 and is stimulated by minor capsid protein VP3. J. Virol. 77(7), 4273-4282 (2003).
60. Kraus WL, Lis JT. PARP goes transcription. Cell 113(6), 677-683 (2003).
61. Cervellera MN, Sala A. Poly(ADP-ribose) polymerase is a B-MYB coactivator. J. Biol. Chem. 275(14), 10692-10696 (2000).
62. Tominaga A, Sugawara H, Futagawa T et al. Characterization of the testis-specific promoter region in the human pituitary adenylate cyclase-activating polypeptide (PACAP) gene. Genes Cells 15(6), 595-606 (2010).
63. Shi L, Ko S, Kim S et al. Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1. J. Biol. Chem. 283(52), 36474-36485 (2008).
64. Wang J, Bian C, Li J, Couch FJ, Wu K, Zhao RC. Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter. J. Biol. Chem. 283(52), 36249-36256 (2008).
65. Chen J, Sun Y, Mao X, Liu Q, Wu H, Chen Y. RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis. J. Biol Chem. 285(47), 36315-36321 (2010).
66. Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, Richmond A. A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J. Biol. Chem. 276(12), 9366-9374 (2001).
67. Choi HS, Hwang CK, Kim CS et al. Transcriptional regulation of mouse mu opioid receptor gene in neuronal cells by poly(ADP-ribose) polymerase-1. J. Cell. Mol. Med. 12(6A), 2319-2333 (2008).
68. Grote J, Konig S, Ackermann D et al. Identification of poly(ADP-ribose) polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression. BMC Mol. Biol. 7, 48 (2006).
69. Li W, Ain KB. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. Endocr. Relat. Cancer 17(2), 383-398 (2010).
70. Chiba-Falek O, Kowalak JA, Smulson ME, Nussbaum RL. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am. J. Hum. Genet. 76(3), 478-492 (2005).
71. Beranger GE, Momier D, Rochet N et al. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis. J. Bone Miner. Res. 21(11), 1757-1769 (2006).
72. Chu S, Xu H, Ferro TJ, Rivera PX. Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(5), L1127-L1134 (2007).
73. Pavri R, Lewis B, Kim TK et al. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol. Cell. 18(1), 83-96 (2005).
74. Sakamaki J, Daitoku H, Yoshimochi K, Miwa M, Fukamizu A. Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1. Biochem. Biophys. Res. Commun. 382(3), 497-502 (2009).
75. Ouararhni K, Hadj-Slimane R, Ait-Si-Ali S et al. The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. Genes Dev. 20(23), 3324-3336 (2006).
76. Lonn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. PARP-1 attenuates Smad-mediated transcription. Mol. Cell 40(4), 521-532 (2010).
77. Hossain MB, Ji P, Anish R, Jacobson RH, Takada S. Poly(ADP-ribose) polymerase 1 interacts with nuclear respiratory factor 1 (NRF-1) and plays a role in NRF-1 transcriptional regulation. J. Biol. Chem. 284(13), 8621-8632 (2009).
78. Li Y, Oh HJ, Lau YF. The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions. Mol. Cell Endocrinol. 257-258, 35-46 (2006).
79. Chen Y, Schnetz MP, Irarrazabal CE et al. Proteomic identification of proteins associated with the osmoregulatory transcription factor TonEBP/OREBP: functional effects of Hsp90 and PARP-1. Am. J. Physiol. Renal. Physiol. 292(3), F981-F992 (2007).
80. Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/b-catenin complex. Gastroenterology 128(7), 1919-1936 (2005).
81. Maeda Y, Hunter TC, Loudy DE, Dave V, Schreiber V, Whitsett JA. PARP-2 interacts with TTF-1 and regulates expression of surfactant protein-B. J. Biol. Chem. 281(14), 9600-9606 (2006).
82. Ju BG, Solum D, Song EJ et al. Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell 119(6), 815-829 (2004).
83. Yu W, Ginjala V, Pant V et al. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat. Genet. 36(10), 1105-1110 (2004).
84. Farrar D, Rai S, Chernukhin I et al. Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol. Cell. Biol. 30(5), 1199-1216 (2010).
85. Aker M, Bomsztyk K, Emery DW. Poly(ADP-ribose) polymerase-1 (PARP-1) contributes to the barrier function of a vertebrate chromatin insulator. J. Biol. Chem. 285(48), 37589-37597 (2010).
86. Caiafa P, Zlatanova J. CCCTC-binding factor meets poly(ADP-ribose) polymerase-1. J. Cell. Physiol. 219(2), 265-270 (2009).
87. Riethoven JJ. Regulatory regions in DNA: promoters, enhancers, silencers, and insulators. Methods Mol. Biol. 674, 33-42 (2010).
88. Gurudatta BV, Corces VG. Chromatin insulators: lessons from the fly. Brief Funct. Genomic Proteomic 8(4), 276-282 (2009).
89. Yusufzai TM, Tagami H, Nakatani Y, Felsenfeld G. CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol. Cell. 13(2), 291-298 (2004).
90. Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas - a tool for pathology. J. Pathol. 216(4), 387-393 (2008).
91. von Minckwitz G, Muller BM, Loibl S et al. Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. J. Clin. Oncol. 29(16), 2150-2157 (2011).
92. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 10(4), 293-301 (2010).
93. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(13), 1229-1239 (2009).
94. Yocum AK, Chinnaiyan AM. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry. Brief Funct. Genomic Proteomic 8(2), 145-157 (2009).
95. Fu Z, Fenselau C. Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance. J. Proteome Res. 4(5), 1583-1591 (2005).
96. Chang DT, Chapman CH, Norton JA et al. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma. Cancer 116(22), 5179-5187 (2010).
97. Jha R, Agarwal A, Mahfouz R et al. Determination of poly (ADP-ribose) polymerase (PARP) homologues in human ejaculated sperm and its correlation with sperm maturation. Fertil. Steril. 91(3), 782-790 (2009).
98. Hottiger MO, Hassa PO, Luscher B, Schuler H, Koch-Nolte F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 35(4), 208-219 (2010).
99. Huambachano O, Herrera F, Rancourt A, Satoh MS. Double-stranded DNA binding domain of poly(ADP-ribose) polymerase-1 and molecular insight into the regulation of its activity. J. Biol. Chem. 286(9), 7149-7160 (2011).
100. Malanga M, Althaus FR. Poly(ADP-ribose) molecules formed during DNA repair in vivo. J. Biol. Chem. 269(26), 17691-17696 (1994).
101. Davidovic L, Vodenicharov M, Affar EB, Poirier GG. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell. Res. 268(1), 7-13 (2001).
102. Rodriguez MI, Gonzalez-Flores A, Dantzer F, Collard J, de Herreros AG, Oliver FJ. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability. Oncogene 30(42), 4365-4372 (2011).
103. Bai P, Canto C, Brunyanszki A et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell. Metab. 13(4), 450-460 (2011).
104. Rulten SL, Fisher AE, Robert I et al. PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol. Cell. 41(1), 33-45 (2011).
105. Tramontano F, Malanga M, Quesada P. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl) ation reaction in rat primary spermatocytes. Mol. Hum. Reprod. 13(11), 821-828 (2007).
106. Lautier D, Lagueux J, Thibodeau J, Menard L, Poirier GG. Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol. Cell. Biochem. 122(2), 171-193 (1993).
107. Schreiber V, Dantzer F, Ame JC, de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7(7), 517-528 (2006).
108. Rouleau M, Aubin RA, Poirier GG. Poly(ADP-ribosyl)ated chromatin domains: access granted. J. Cell Sci. 117(Pt 6), 815-825 (2004).
109. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res. 37(11), 3723-3738 (2009).
110. Hottiger MO. ADP-ribosylation of histones by ARTD1: an additional module of the histone code? FEBS Lett. 585(11), 1595-1599 (2011).
111. Tao Z, Gao P, Liu HW. Identification of the ADP-ribosylation sites in the PARP-1 utomodification domain: analysis and implications. J. Am. Chem. Soc. 131(40), 14258-14260 (2009).
112. Margarit SM, Davidson W, Frego L, Stebbins CE. A steric antagonism of actin polymerization by a salmonella virulence protein. Structure 14(8), 1219-1229 (2006).
113. Hengel SM, Shaffer SA, Nunn BL, Goodlett DR. Tandem mass spectrometry investigation of ADP-ribosylated kemptide. J. Am. Soc. Mass Spectrom. 20(3), 477-483 (2009).
114. Messner S, Altmeyer M, Zhao H et al. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res. 38(19), 6350-6362 (2010).
115. Trost M, Bridon G, Desjardins M, Thibault P. Subcellular phosphoproteomics. Mass Spectrom. Rev. 29(6), 962-990 (2010).
116. Ashman K, Villar EL. Phosphoproteomics and cancer research. Clin. Transl. Oncol. 11(6), 356-362 (2009).
117. Bauer PI, Farkas G, Mihalik R, Kopper L, Kun E, Farago A. Phosphorylation of poly(ADP-ribose)polymerase protein in human peripheral lymphocytes stimulated with phytohemagglutinin. Biochim. Biophys. Acta 1223(2), 234-239 (1994).
118. Aoufouchi S, Shall S. Regulation by phosphorylation of Xenopus laevis poly(ADP-ribose) polymerase enzyme activity during oocyte maturation. Biochem. J. 325(Pt 2), 543-551 (1997).
119. Beckert S, Farrahi F, Perveen Ghani Q et al. IGF-I-induced VEGF expression in HUVEC involves phosphorylation and inhibition of poly(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 341(1), 67-72 (2006).
120. Kauppinen TM, Chan WY, Suh SW, Wiggins AK, Huang EJ, Swanson RA. Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc. Natl Acad. Sci. USA 103(18), 7136-7141 (2006).
121. Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM. c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ. 14(5), 1001-1010 (2007).
122. Gagne JP, Moreel X, Gagne P et al. Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase. J. Proteome Res. 8(2), 1014-1029 (2009).
123. Matsuoka S, Ballif BA, Smogorzewska A et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316(5828), 1160-1166 (2007).
124. Mayya V, Lundgren DH, Hwang SI et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. 2(84), ra46 (2009).
125. Dephoure N, Zhou C, Villen J et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl Acad. Sci. USA 105(31), 10762-10767 (2008).
126. Nagano K, Shinkawa T, Mutoh H et al. Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment. Proteomics 9(10), 2861-2874 (2009).
127. Malik R, Lenobel R, Santamaria A, Ries A, Nigg EA, Korner R. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J. Proteome Res. 8(10), 4553-4563 (2009).
128. Bennetzen MV, Larsen DH, Bunkenborg J, Bartek J, Lukas J, Andersen JS. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell Proteomics 9(6), 1314-1323 (2010).
129. Olsen JV, Vermeulen M, Santamaria A et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3(104), ra3 (2010).
130. Iliuk AB, Martin VA, Alicie BM, Geahlen RL, Tao WA. In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol. Cell Proteomics 9(10), 2162-2172 (2010).
131. Moritz A, Li Y, Guo A et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3(136), ra64 (2010).
132. Rigbolt KT, Prokhorova TA, Akimov V et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 4(164), rs3 (2011).
133. Santamaria A, Wang B, Elowe S et al. The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol. Cell. Proteomics 10(1), M110.004457 (2011).
134. Yang XJ, Seto E. Lysine acetylation: codified crosstalk with otherposttranslational modifications. Mol. Cell. 31(4), 449-461 (2008).
135. Arif M, Senapati P, Shandilya J, Kundu TK. Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochim. Biophys. Acta 1799(10-12), 702-716 (2010).
136. Mischerikow N, Heck AJ. Targeted large-scale analysis of protein acetylation. Proteomics 11(4), 571-589 (2011).
137. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. Transcriptional coactivation of nuclear factor-kB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J. Biol. Chem. 278(46), 45145-45153 (2003).
138. Hassa PO, Haenni SS, Buerki C et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J. Biol. Chem. 280(49), 40450-40464 (2005).
139. Rajamohan SB, Pillai VB, Gupta M et al. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol. Cell. Biol. 29(15), 4116-4129 (2009).
140. Choudhary C, Kumar C, Gnad F et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942), 834-840 (2009).
141. Bergink S, Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458(7237), 461-467 (2009).
142. Shi Y, Xu P, Qin J. Ubiquitinated proteome: ready for global? Mol. Cell. Proteomics 10(5), R110.006882 (2011).
143. Al-Hakim A, Escribano-Diaz C, Landry MC et al. The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair 9(12), 1229-1240 (2010).
144. Malynn BA, Ma A. Ubiquitin makes its mark on immune regulation. Immunity 33(6), 843-852 (2010).
145. Kirkin V, Dikic I. Ubiquitin networks in cancer. Curr. Opin. Genet. Dev. 21(1), 21-28 (2011).
146. Xu G, Paige JS, Jaffrey SR. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 28(8), 868-873 (2010).
147. Danielsen JM, Sylvestersen KB, Bekker-Jensen S et al. Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol. Cell. Proteomics 10(3), M110.003590 (2011).
148. Wang T, Simbulan-Rosenthal CM, Smulson ME, Chock PB, Yang DC. Polyubiquitylation of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD+, and dipeptides. J. Cell. Biochem. 104(1), 318-328 (2008).
149. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl Acad. Sci. USA 96(11), 6223-6228 (1999).
150. Mayer-Kuckuk P, Ullrich O, Ziegler M, Grune T, Schweiger M. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro. Biochem. Biophys. Res. Commun. 259(3), 576-581 (1999).
151. Arnold J, Grune T. PARP-mediated proteasome activation: a co-ordination of DNA repair and protein degradation? Bioessays 24(11), 1060-1065 (2002).
152. Catalgol B, Wendt B, Grimm S, Breusing N, Ozer NK, Grune T. Chromatin repair after oxidative stress: role of PARP-mediated proteasome activation. Free Radic. Biol. Med. 48(5), 673-680 (2010).
153. Zhang Y, Liu S, Mickanin C et al. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat. Cell. Biol. 13(5), 623-629 (2011).
154. Andrabi SA, Kang HC, Haince JF et al. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat. Med. 17(6), 692-699 (2011).
155. Hannoun Z, Greenhough S, Jaffray E, Hay RT, Hay DC. Post-translational modification by SUMO. Toxicology 278(3), 288-293 (2010).
156. Rosas-Acosta G, Russell WK, Deyrieux A, Russell DH, Wilson VG. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4(1), 56-72 (2005).
157. Blomster HA, Hietakangas V, Wu J, Kouvonen P, Hautaniemi S, Sistonen L. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol. Cell. Proteomics 8(6), 1382-1390 (2009).
158. Golebiowski F, Matic I, Tatham MH et al. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2(72), ra24 (2009).
159. Galisson F, Mahrouche L, Courcelles M et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol. Cell. Proteomics 10(2), M110.004796 (2011).
160. Messner S, Schuermann D, Altmeyer M et al. Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J. 23(11), 3978-3989 (2009).
161. Martin N, Schwamborn K, Schreiber V et al. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J. 28(22), 3534-3548 (2009).
162. Ryu H, Al-Ani G, Deckert K et al. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes. J. Biol. Chem. 285(19), 14415-14423 (2010).
163. Matic I, Schimmel J, Hendriks IA et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell. 39(4), 641-652 (2010).
164. Miller MJ, Barrett-Wilt GA, Hua Z, Vierstra RD. Proteomic analyses identify a diverse array of nuclear processes affected by small ubiquitin-like modifier conjugation in Arabidopsis. Proc. Natl Acad. Sci. USA 107(38), 16512-16517 (2010).
165. Fahrer J, Popp O, Malanga M et al. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length. Biochemistry 49(33), 7119-7130 (2010).